Drug maker Eli Lilly And Co. (LLY), while reporting higher earnings and weak revenues in its fourth quarter, on Thursday lifted its fiscal 2023 earnings view above market estimates, as it has updated the tax rate guidance.
from RTT - Before the Bell https://ift.tt/hnTeutk
via IFTTT
No comments:
Post a Comment